NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

US STOCKS-S&P, Dow futures rise after Moderna says vaccine 94.5% effective

Published 16/11/2020, 14:12
© Reuters.
US500
-
US2000
-
UAL
-
IXIC
-
AAL
-
MRNA
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* Moderna jumps after COVID-19 vaccine update; Pfizer falls
* Banks, airlines, cruise operators rally
* Stay-at-home winners Netflix, Amazon fall
* Futures: Dow up 1.62%, S&P up 1.07%, Nasdaq flat

(Adds comment, details; Updates prices)
By Medha Singh and Shivani Kumaresan
Nov 16 (Reuters) - Futures tracking the S&P 500 and the Dow
rose on Monday after Moderna became the second U.S. company in a
week to report positive results from its COVID-19 vaccine trial,
raising hopes of a quicker economic recovery from a pandemic-led
recession.
Moderna Inc MRNA.O soared 15% in premarket trading as it
said its experimental vaccine was 94.5% effective in preventing
COVID-19 based on interim data from a late-stage trial.
Nasdaq 100 futures NQcv1 fell as investors again sold some
of this year's "stay-at-home" winners, although gains of about a
percent for Dow 1YMcv1 and S&P 500 futures EScv1 were less
stellar than those after a similar release from Pfizer Inc
PFE.N a week ago.
Travel-related stocks including United Airlines Holdings Inc
UAL.O , American Airlines Group Inc AAL.O , Carnival Corp
CCL.N and Norwegian Cruise Line Holdings Ltd NCLH.N , which
have lost more than half their market capitalization this year
due to the pandemic, jumped between 7% and 10%.
"This enables managers to now more broadly expose their
portfolios to new pockets of growth," said Thomas Hayes,
managing member at Great Hill Capital Llc in New York.
"You could potentially have a little bit of profit-taking in
the morning, but on balance there's not much to sell in this
news in the fact that most (fund) managers went into the
election flatfooted and now they've got to play catch up in the
year end."
Bets of a working COVID-19 vaccine fueled gains on Wall
Street last week, helping investors look past surging
coronavirus cases across the United States which topped the 11
million mark, just over a week after hitting 10 million.
The benchmark S&P 500 .SPX and the small-cap Russell 2000
.RUT ended Friday at record closing highs, while the
technology-heavy Nasdaq .IXIC fell slightly.
At 7:50 a.m. ET, Dow e-minis 1YMcv1 were up 475 points, or
1.62%, S&P 500 e-minis EScv1 were up 38.25 points, or 1.07%,
and Nasdaq 100 e-minis NQcv1 were down 2.5 points, or nearly
flat.
Big U.S. banks JPM.N GS.N MS.N gained between 2.5% and
3.3%, building on gains from last week, while Boeing Co BA.N
and Chevron Corp CVX.N jumped more than 3%.
Better-than-expected factory output data from China also
bolstered optimism about a rebound from a coronavirus-induced
slump, pushing global stocks closer to record highs on Monday.
MKTS/GLOB
Among other stocks, Simon Property Group Inc SPG.N jumped
10.2% after the biggest U.S. mall operator cut its purchase
price for an 80% stake of rival Taubman Centers Inc TCO.N , as
the virus outbreak upends the retail industry sector.
Johnson & Johnson JNJ.N gained 1.5% after launching a new
large-scale study to test a two-dose regimen of its experimental
COVID-19 vaccine.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.